Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Some systemic treatments work for nail psoriasis but can have serious side effects.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

Cleanroom workers in a battery factory have worse skin and eye conditions due to the very dry environment.

The Egyptian Arabic Skindex-16 is a reliable way to measure how skin diseases affect quality of life in Egyptian patients.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

Skin diseases, especially psoriasis, greatly affect people's quality of life, similar to chronic diseases.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Hyperbaric oxygen therapy improves hair growth and quality of life in androgenic alopecia patients.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

The Thai version of the Family Dermatology Life Quality Index is a reliable and valid tool for assessing the quality of life of patients' families.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Female pattern hair loss greatly affects women's quality of life, causing mild depression and anxiety, and increases medical expenses.

The Turkish version of the MAIA-2 Scale is valid and reliable for patients at a dermatology clinic.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.

The conclusion is that "trichoknesis" should be recognized as a separate condition from trichodynia, characterized by itching instead of pain.

Portuguese WAA-QoL questionnaire validated; FPHL severity, schooling, and phototypes affect patients' quality of life.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Hair loss lowers young men's self-esteem, increasing social anxiety and affecting daily life.